TILRAY BRANDS INC Stock Price, News & Analysis

Tilray Brands, a leading cannabis-lifestyle company, will release its third-quarter fiscal 2022 financial results on April 6, 2022, before market open. The conference call is set for 8:30 AM ET on the same day. Shareholders can submit questions via the Say Technologies platform up until 24 hours before the call. Tilray operates globally with over 20 brands across various markets, aiming to enhance well-being through high-quality products. This information comes as part of their ongoing commitment to transparency and shareholder engagement.

Tilray Brands, Inc. has launched its new Renew Moonlight CBN vape pen across Canada, expanding its wellness brand, Solei. This product is designed for nighttime use, featuring a 4:1 THC to CBN ratio, enhanced with citrus and herbal aromas. Brand Manager Danielle Minard emphasizes the product's role in promoting a smoother evening routine. The launch aims to augment Solei's award-winning portfolio of wellness offerings, which already includes popular CBD oils and THC vapes.

Tilray Brands has expanded its medical cannabis offerings by launching the first EU GMP medical cannabis oil products in Malta. This move allows patients across Malta to access high-quality cannabis through pharmacies. Denise Faltischek, Chief Strategy Officer, highlighted the growing demand for medical cannabis in the region. With a strong track record in the EU market, Tilray continues to be a significant supplier of medical cannabis products, serving patients in over 20 countries worldwide.

Tilray Brands, Inc. (Nasdaq: TLRY) has launched Good Supply Hash Bats™, a new line of hash-infused pre-rolls, which debuted in Ontario in February 2022. The product combines popular strains Jean Guy and Starwalker Kush with hash, offering a higher potency option at 26% THC, exceeding the typical pre-roll THC levels by 5%. The Good Supply brand is well-regarded in Canada and aims to deliver a superior smoking experience. Hash Bats are set for a broader national rollout in April and May 2022.

Tilray Brands has announced its intention to acquire HEXO Corp.’s senior secured convertible notes valued at up to US$211 million. This strategic alliance aims to enhance operational efficiencies and product innovation, benefiting both companies. The acquisition is projected to yield approximately C$20 million in interest payments during the first year, adding 4 cents to future earnings per share. Furthermore, both companies expect to realize up to C$50 million in shared cost synergies over the next two years, with Tilray nominating a member to HEXO’s Board upon closure.

Manitoba Harvest is set to showcase its innovative Hemp food products at Natural Products Expo West from March 10-12, 2022, in Anaheim, CA. The brand will unveil a new lineup that includes Hemp Protein powders blended with Matcha and Kale, as well as convenient formats like Ground Hemp Seeds. These products aim to enhance consumer wellness by leveraging hemp's rich protein and omega content. With a history since 1998, Manitoba Harvest, a subsidiary of Tilray Brands (NASDAQ: TLRY), emphasizes quality and sustainability in their hemp-based offerings.

SweetWater Brewing Company, a subsidiary of Tilray Brands, is expanding its craft beer distribution into Washington and Oregon in partnership with Columbia Distributing. This move follows a recent launch in California and marks the 39th and 40th states for product availability. As SweetWater celebrates its 25th anniversary, it continues to grow, showcasing its flagship beers like SweetWater 420 Extra Pale Ale. The expansion underscores the brand's success and strategic growth plans within the craft beer market.

MedMen Enterprises Inc. (CSE: MMEN, OTCQX: MMNFF) has appointed Ana Bowman as Chief Financial Officer, effective February 22, 2022. She succeeds interim CFO Reece Fulgham, who will return to consulting. Bowman has extensive cannabis industry experience, having served as Vice President of Financial Reporting at Tilray Brands (NASDAQ: TLRY). MedMen operates across several states in the U.S. and offers a variety of cannabis products through its retail stores and loyalty program.

Tilray Brands, Inc. (TLRY) has announced the successful sale of its medical cannabis products in Malta, marking a significant expansion for its medical cannabis division, Tilray Medical. With EU-GMP certification, these products are now accessible in pharmacies across the country, providing Maltese patients with reliable access to high-quality medical cannabis. Chief Strategy Officer Denise Faltischek highlighted the growing demand for cannabis in Europe and emphasized the company's role in partnering with trusted distributors. This milestone reinforces Tilray's commitment to delivering safe cannabis products globally.